Related Experiment Video
Updated: Feb 13, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Allogeneic stem cell transplantation for relapsed primary central nervous system lymphoma: Is it feasible?
Erden Atilla1, Ugur Sahin1, Pinar Ataca Atilla1
1Ankara University School of Medicine, Department of Hematology, Cebeci, Ankara, Turkey.
Abstract:
Primary central nervous system lymphoma (PCNSL), has an aggressive course and in untreated patients median survival is limited to three months. For relapsed PCNSL, the treatment options are few and results are usually unsatisfactory. Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT) has been widely used for treatment of relapsed/refractory NHL patients. However there are limited data whether graft versus lymphoma effect can work in PCNSL patients. Here, we present a relapsed refractory PCNSL case treated by allo-HCT.
Related Concept Videos
What is a Nervous System?
The Parasympathetic Nervous System
Induced Pluripotent Stem Cells
The Sympathetic Nervous System
Adult Stem Cells
Embryonic Stem Cells

